Soluble PD-L1 generated by endogenous retroelement exaptation is a receptor antagonist

Autor: Spyros I. Papamichos, Kevin W. Ng, George R. Young, Eleonora Ottina, Jan Attig, George Kassiotis, Ioannis Kotsianidis
Rok vydání: 2019
Předmět:
0301 basic medicine
Untranslated region
retroelement
B7-H1 Antigen
Immunology and Inflammation
0302 clinical medicine
Biology (General)
Receptor
Conserved Sequence
Chemistry
General Neuroscience
Hominidae
Biological activity
Exons
General Medicine
Chromosomes and Gene Expression
Receptor antagonist
3. Good health
Cell biology
Transmembrane domain
medicine.anatomical_structure
Regulatory sequence
030220 oncology & carcinogenesis
Medicine
Research Article
Human
PD-L1
Retroelements
receptor antagonist
QH301-705.5
medicine.drug_class
Science
T cell
LINE
General Biochemistry
Genetics and Molecular Biology

Evolution
Molecular

03 medical and health sciences
Protein Domains
mental disorders
medicine
Animals
Humans
Gene
Cell Proliferation
Immunosuppression Therapy
General Immunology and Microbiology
Mice
Inbred C57BL

Alternative Splicing
HEK293 Cells
030104 developmental biology
Solubility
Zdroj: eLife, Vol 8 (2019)
eLife
ISSN: 2050-084X
Popis: Immune regulation is a finely balanced process of positive and negative signals. PD-L1 and its receptor PD-1 are critical regulators of autoimmune, antiviral and antitumoural T cell responses. Although the function of its predominant membrane-bound form is well established, the source and biological activity of soluble PD-L1 (sPD-L1) remain incompletely understood. Here, we show that sPD-L1 in human healthy tissues and tumours is produced by exaptation of an intronic LINE-2A (L2A) endogenous retroelement in the CD274 gene, encoding PD-L1, which causes omission of the transmembrane domain and the regulatory sequence in the canonical 3’ untranslated region. The alternatively spliced CD274-L2A transcript forms the major source of sPD-L1 and is highly conserved in hominids, but lost in mice and a few related species. Importantly, CD274-L2A-encoded sPD-L1 lacks measurable T cell inhibitory activity. Instead, it functions as a receptor antagonist, blocking the inhibitory activity of PD-L1 bound on cellular or exosomal membranes.
Databáze: OpenAIRE